Texas Capital Bancshares Inc/Tx (TCBIO) Change in Accured Expenses (2011 - 2026)

Texas Capital Bancshares (TCBIO) has reported Change in Accured Expenses for 16 consecutive years, with -$6.4 million the latest figure, recorded in Q2 2026.

• Quarterly Change in Accured Expenses fell 128.62% year-over-year to -$6.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$50.2 million (down 250.48% YoY) and the FY2025 annual result came in at -$68.9 million, down 277.28% from the prior year.
• Change in Accured Expenses improved to -$6.4 million in Q2 2026 per TCBIO's latest filing, from -$43.1 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for TCBIO reached as high as $195.6 million in Q3 2024 and fell as low as -$141.7 million in Q4 2024.
• A 5-year average of -$2.7 million and a median of -$4.6 million in 2023 frame the typical range for Change in Accured Expenses.
• The largest YoY upside for Change in Accured Expenses was 591.81% in 2024 against a maximum downside of 421.88% in 2024.
• Year by year, Change in Accured Expenses stood at -$11.7 million in 2022, then jumped by 474.74% to $44.0 million in 2023, then slumped by 421.88% to -$141.7 million in 2024, then jumped by 98.14% to -$2.6 million in 2025, then tumbled by 141.62% to -$6.4 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$6.4 million, -$43.1 million, and -$2.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.